PAUL J CHUBA, MD
Radiology at Mack Ave, Detroit, MI
License number
Michigan 059239
Category
Radiology
Type
Radiation Oncology
License number
Michigan 4301059239
Category
Radiology
Type
Radiation Oncology
Address
Address
19229 Mack Ave SUITE 10, Detroit, MI 48236
Phone
(313) 647-3100
(313) 647-3111 (Fax)
(313) 647-3111 (Fax)
Professional information
Dr. Paul J Chuba, Warren MI - MD (Doctor of Medicine)
Specialties:
Radiation Oncology
Address:
Radiation Oncology Specialists
11800 E Twelve Mile Rd, Warren 48093
(586) 573-5186 (Phone)
11800 E Twelve Mile Rd, Warren 48093
(586) 573-5186 (Phone)
Conditions:
Vulvar Cancer
Certifications:
Radiation Oncology, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Radiation Oncology Specialists
11800 E Twelve Mile Rd, Warren 48093
Saint John Hospital & Medical Center
22101 Moross Rd, Detroit 48236
Saint John Macomb - Oakland Hospital - Macomb Center
11800 East Twelve Mile Rd, Warren 48093
11800 E Twelve Mile Rd, Warren 48093
Saint John Hospital & Medical Center
22101 Moross Rd, Detroit 48236
Saint John Macomb - Oakland Hospital - Macomb Center
11800 East Twelve Mile Rd, Warren 48093
Education:
Medical School
Wayne State University
Graduated: 1992
St John Hospital and Med Center
Wayne St University Detroit M C
Wayne State University
Graduated: 1992
St John Hospital and Med Center
Wayne St University Detroit M C
Paul J Chuba, Grosse Pointe Woods MI
Specialties:
Oncologist
Address:
19229 Mack Ave, Grosse Pointe Woods, MI 48236
11800 E 12 Mile Rd, Warren, MI 48093
11800 E 12 Mile Rd, Warren, MI 48093
Education:
Doctor of Medicine
Board certifications:
American Board of Radiology Certification in Radiation Oncology (Radiology)
Method For Detecting Lyme Disease
US Patent:
5494797, Feb 27, 1996
Filed:
Jul 8, 1994
Appl. No.:
8/272274
Inventors:
Daisy S. McCann - Ontario, CA
Paul Chuba - Detroit MI
Paul Chuba - Detroit MI
Assignee:
McCann Associates, Inc. - Wayne MI
International Classification:
C12Q 168
US Classification:
435 6
Abstract:
Described is a method of detecting the presence of Lyme Disease organism comprising the steps of (a) combining a sample with an oligonucleotide probe for the organism; (b) hybridizing the probe with the organism; and (c) determining the presence of the organism hybridized with the probe. Also described is a kit containing a hybridization buffer, a labeled probe, and filter assemblies on which the hybridized product may be placed during the hybridization reaction. The kit may also contain positive and negative control filters to assist in the evaluation of unknown specimens.